Study of CD38 and CD56 in Chronic Myeloid Leukemia
ConditionChronic Myeloid Leukemia (CML)
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorSohag University
About this trial
Chronic myeloid leukemia is a myelo-proliferative neoplasm characterized by abnormal proliferation of myeloid cells. There is an accumulation of mature granulocytes in the blood and bone marrow.
The aim of the study is to study expression of CD38 and CD56 in patients with Chronic myeloid leukemia.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
patients with chronic myeloid leukemia
Disqualifiers
other hematological diseases
Trial population
patients in sohag city
Trial design
Design model
Case-control
Time perspective
Prospective
Treatments tested in this trial
cd 38 and cd 56
Diagnostic testprescence of high percentage of cd38 and cd 56
Treatment groups
200 Participants
are divided into 2 treatment groupsGroup A: chronic myeloid leukemia group1 intervention
Group B: healthy group0 interventions
Trial outcomes
Primary outcomes
1
an increased change in cd 38 and cd 56 in chronic leukemic patients
Time frame
6 monthsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: